Literature DB >> 1435478

Successful treatment of disseminated strongyloidiasis.

C Coulter1, D G Walker, M Günsberg, I G Brown, J F Bligh, P Prociv.   

Abstract

OBJECTIVE: To report the successful treatment of Strongyloides stercoralis hyperinfection, which is usually lethal but in this case was diagnosed in its early stages. CLINICAL FEATURES: A 44-year-old woman, who had spent much of her life in Fiji and India, was treated with a high dose of prednisolone for rheumatoid arthritis complicated by gold lung. The onset of abdominal symptoms, an exacerbation of respiratory symptoms, and a persistent high eosinophil count and serum IgE level, led to the detection of numerous Strongyloides larvae in her faeces and sputum. INTERVENTION AND OUTCOME: She was treated with thiabendazole for five days, then mebendazole for one month, and the dose of prednisolone was reduced. Clinical symptoms and signs improved within days and after one week parasites could not be found in her faeces. After six months, enzyme-linked immunosorbent assay for Strongyloides infection gave a reading which was 40% of the initial level but still in the positive range.
CONCLUSION: Steroid therapy in individuals with chronic, subclinical strongyloidiasis predisposes to the insidious development of hyperinfection syndrome, which has a high mortality rate. If detected early, this complication can be treated effectively. It can be prevented by actively seeking Strongyloides infection, by faecal microscopy and culture techniques and by serological tests, in high-risk individuals, such as immigrants from endemic areas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435478

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

Review 1.  Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review.

Authors:  Alireza Ashiri; Molouk Beiromvand; Abdollah Khanzadeh
Journal:  Clin Rheumatol       Date:  2019-05-23       Impact factor: 2.980

Review 2.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 3.  Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature.

Authors:  Guillaume Geri; Antoine Rabbat; Julien Mayaux; Lara Zafrani; Ludivine Chalumeau-Lemoine; Bertrand Guidet; Elie Azoulay; Frédéric Pène
Journal:  Infection       Date:  2015-05-26       Impact factor: 7.455

4.  Short communication: Epidemiological assessment of Strongyloides stercoralis in Fijian children.

Authors:  S H Kim; M Rinamalo; M Rainima-Qaniuci; N Talemaitoga; M Kama; E Rafai; M-H Choi; S T Hong; J J Verweij; L Kelly-Hope; J R Stothard
Journal:  Parasite Epidemiol Control       Date:  2016-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.